Potential use of bacterial pigments as anticancer drugs and female reproductive toxicity: a review
Abstract
Natural bioactive compounds obtained from microorganisms have awakened particular interest in the industry in recent years. This attention comes when the depletion of natural resources is pronounced, and the acquisition of new inputs and bioactive products of plant origin represents a challenge for the next generations. In this sense, prospecting for the large-scale production and use of bacterial pigments has represented a necessary strategy for the development of novel products. A wide variety of properties have been attributed to these substances, among them, the therapeutic potential against important diseases, such as cancer. There is consensus that available chemotherapy protocols are known to detrimentally affect the fertility of cancer patients. A considerable part of the deleterious effects of chemotherapy is related to the cytotoxicity of the drugs used for this purpose, which, in addition to cancer cells, affect normal cells. In this sense, the intrinsic properties attributed to bacterial pigments associated with low cytotoxicity and relevant cell selectivity certified them as potential anticancer drugs. However, little information is available about the reproductive toxicity of these new and promising compounds. Thus, the present review aims to address the main bacterial pigments, their potential uses as anticancer drugs, and their possible toxic effects, especially on the female gonad.
Keywords: cancer; chemotherapy; fertility; bioactive compounds; bacteria
Downloads
![](https://revistas.ufg.br/public/journals/10/submission_72911_70220_coverImage_pt_BR.jpg)
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Brazilian Animal Science/ Ciência Animal Brasileira
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).